TACSTD2 and breast cancer: We hypothesized that CBP would disrupt the tumor neovascular, thereby enhancing infiltration of the CAR-T cells.<h4>Methods</h4>Analyzed TROP-2 expression in breast cancer using bioinformatics, qRT-PCR, and sequencing.